Compounded Tirzepatide + B12 · 3-Month Plan

Description

Tirzepatide / B12 (2 mL) 20/1 mg/mL is a compounded injectable medication (also known as Tirzepatide / Cyanocobalamin or Vitamin B12) prepared for subcutaneous administration. This high-concentration formulation in a moderate 2 mL vial supports efficient dosing for higher maintenance levels, extended treatment periods, and reduced injection volumes compared to lower-concentration options.

This formulation combines:

• Tirzepatide (20 mg/mL) — a dual GIP and GLP-1 receptor agonist that imitates the natural hormones GIP and GLP-1. It enhances glucose-dependent insulin release, suppresses glucagon, slows gastric emptying, dramatically reduces appetite, increases satiety, and facilitates significant weight loss (typically 15–22%+ body weight in clinical studies) when paired with a reduced-calorie diet and increased physical activity. It is commonly used for chronic weight management in adults with obesity or overweight with weight-related conditions, and for glycemic control in type 2 diabetes (under physician supervision).
• Cyanocobalamin (Vitamin B12) (1 mg/mL) — included to help sustain energy production, support red blood cell formation, aid metabolic processes, and promote neurological health. During calorie restriction or tirzepatide therapy, some individuals may encounter fatigue, potential B12 deficiencies, or side effects like nausea; the added B12 (at this higher 1 mg/mL level) is intended to help offset these, boost vitality, improve energy, and enhance treatment tolerance and adherence.